DIRS.INFO The most relevant business & tech news

Her case is far from unique, however: Hospitals across the United States have said they’re taking steps to conserve their supply of IV fluids, including postponing or canceling nonemergency surgeries. IV fluids do more than deliver drugs or electrolytes directly into a patient’s bloodstream. On Monday, the AHA urged President Joe Biden to declare a nationwide emergency over the limited supply of IV fluids. She’s been dependent on IV nutrition, which delivers nutrients directly into her bloodstream, for more than eight years. Hannah Hale, in 2016 on her first day home after a long hospitalization, with her TPN, or IV nutrition.

Persons: Yvonne Hemz, Abbott Northwestern, Hurricane Helene, Hemze, hasn’t, ”, They’re, Chris DeRienzo, Joe Biden, Hannah Hale, Baxter, Hale, She’s, “, ” Hale, It’s, won’t, ASPR, Alli Longenhagen, Kabi, they’ve, Paul Biddinger, Brigham, Robert, Robert —, —, I’m Organizations: Baxter International, NBC News, Health, Abbott Northwestern, Allina Health, Gatorade, American Hospital Association, AHA, The New York Times, NBC, Food and Drug Administration, U.S, FDA, Administration, Strategic Preparedness, Department of Health, Human Services, Braun, Mass Locations: Farmington , Minnesota, North Carolina, United States, U.S, Dallas, Canada, China, Ireland, United Kingdom, Hale, Daytona Beach , Florida, Hurricane Milton, Boston, Chicago

☆ This highly profitable industry is booming as the population ages
▼ + stars: | 2023-10-15 | by ( Michelle Fox | ) www.cnbc.com time to read: +10 min

Enteral nutrition is administered through a feeding tube or it can be taken orally. Fresenius owns 32% of Fresenius Medical Center, which saw shares drop on recent news that Ozempic's kidney disease treatment trial showed signs of success. Clinical nutrition is about 20% of group profits and an important subset of its larger specialized nutrition unit, Ackerman said. "Many investors only focus only on their infant formula unit and don't know how big or how profitable clinical nutrition is," he said. "Clinical nutrition is the jewel in Danone's crown and probably the most attractive part of Danone's portfolio, yet is hidden from investors."

Persons: Stefano Natella, — hasn't, Hassan Al, Wakeel, Warren Ackerman, Ackerman, Lindsay Clarke, Enteral, Danone's Nutrison, —, Baxter, Abbott, Sara Hennicken, Fresenius, Nestlé, Mark Schneider, Nestle, — CNBC's Michael Bloom Organizations: Guggenheim, World Health Organization, WHO, Barclays, Danone, Fresenius, Al, Alliance for Aging Research, Aging, CNBC, Nestle, Companies, — Nestle, Nutrition, Fresenius Medical Locations: German, Paris, China, Swiss, United States, parenteral, Latin America

☆ Fresenius to assess whether state aid impacts bonus, dividend payouts
▼ + stars: | 2023-09-30 | by ( ) www.reuters.com time to read: +2 min

Companies Fresenius SE & Co KGaA FollowFRANKFURT, Sept 30 (Reuters) - German healthcare group Fresenius (FREG.DE) said it was examining whether the state aid it received to help offset high energy costs at its hospitals business would bar it from making management bonus and dividend payments. When asked whether the company would legally challenge any ban on payouts, he said that would have to be analysed. The company paid an unchanged annual dividend of 0.92 euros a share this year, or 518 million euros in total. The spokesperson said the assessment would inform a decision on whether state aid will be accepted during the second half. The Helios unit posted earnings before interest and tax of 622 million euros in the first half against 609 million a year earlier.

Persons: Michael Sen, Sen, Helios, Ludwig Burger, Jan Harvey Organizations: Frankfurter Allgemeine, Reuters, Helios, Thomson Locations: FRANKFURT

☆ Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant
▼ + stars: | 2023-07-20 | by ( Lucy Raitano | ) www.reuters.com time to read: +2 min

Nearly 25 percent of all sterile injectables used in U.S. hospitals are produced at the Rocky Mount facility, according to Pfizer's website. Hikma shares rose by as much as 9.4% in their largest one-day increase since last September, hitting an 18-month high. Pfizer is the largest supplier in the U.S. injectables market and Hikma is the second-largest, analysts said. Hikma has a market value of around $5.6 billion, compared with Pfizer's $205.7 billion and Fresenius SE's $16.7 billion, according to Refinitiv data. Pfizer shares were up 0.16% in premarket trading.

Persons: Fresenius, Max Herrmann, Herrmann, Hikma, J.P.Morgan, Amanda Cooper, Jan Harvey, Mike Harrison Organizations: Pfizer, Rocky, U.S . Food, Drug Administration, Thomson Locations: U.S, Rocky Mount, North Carolina, Hikma

☆ U.S. seeks new suppliers of highly used cancer drug methotrexate in short supply
▼ + stars: | 2023-06-09 | by ( ) www.cnbc.com time to read: +2 min

The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two other scarce chemotherapy medicines. An FDA spokesperson told Reuters the agency is looking for temporary importation options for the drug, which has been in shortage since March. Methotrexate is an injected drug used to treat a wide variety of cancers ranging from acute lymphoblastic leukemia in children, breast cancer, lung cancer, bone cancers and certain types of head and neck cancers, according to the National Cancer Institute. Last week, the FDA said it was looking for additional temporary suppliers for two other cancer chemotherapies, cisplatin and carboplatin. According to the American Society of Health-System Pharmacists, suppliers with methotrexate injections in shortage or on back order include Accord Healthcare, Fresenius Kabi, Pfizer , Teva and Hikma Pharmaceuticals .

Persons: Methotrexate, cisplatin, China's, Senators Gary Peters, Debbie Stabenow, Fresenius Kabi Organizations: . Food, Drug Administration, FDA, Reuters, National Cancer Institute, Pharmaceutical, U.S, Senators, Intas Pharmaceuticals, Healthcare, American Society of Health, System Pharmacists, Accord Healthcare, Pfizer, Teva, Hikma Pharmaceuticals Locations: United States, India, U.S

☆ Fresenius Medical's operating profit drops less than feared as labour shortages ease
▼ + stars: | 2023-05-09 | by ( Ludwig Burger | ) www.reuters.com time to read: +2 min

FRANKFURT, May 9 (Reuters) - Fresenius Medical Care (FMEG.DE) said on Tuesday labour shortages were slowly easing as the German dialysis specialist reported a drop in its first-quarter adjusted operating income, although not as steep as feared by some analysts. The company said in a statement on Tuesday its adjusted operating income dropped to 354 million euros ($390 million), compared with the median analysts' estimate of 335 million in a consensus posted on the company's website. The dialysis group's parent Fresenius SE (FREG.DE) has said this year it would cede control over the struggling dialysis firm, but keep its stake for now as part of a turnaround plan. Fresenius Medical, which was hit hard by a high rate of COVID-19 deaths among its patients, said this burden was easing, though excess mortality for now continued to weigh on growth. Its parent company, German healthcare group Fresenius (FREG.DE), said on Tuesday its first-quarter operating earnings slipped a currency-adjusted 10%.

Healthcare group Fresenius (FREG.DE) said late on Tuesday it would give up strategic control over FMC via a planned change of the division's legal form, also releasing annual results and an outlook that failed to impress investors. Fresenius CEO Michael Sen, a former E.ON (EONGn.DE) and Siemens (SIEGn.DE) executive who took over the helm in October, wants to simplify the company's structure but said he will hang onto the 32% stake Fresenius owns in FMC. This makes a sale more likely in the future, said Florian Oberhofer, portfolio manager at Union Investment, which holds 0.26% of Fresenius shares. Sen said Fresenius was banking on a business improvement at FMC and Vamed and on participating financially in this through its holdings in both. FMC and Fresenius shares lagReporting by Ludwig Burger and Patricia Weiss; Additional reporting by Christoph Steitz; Writing by Rachel More; Editing by Josephine Mason, Elaine Hardcastle and Alexander SmithOur Standards: The Thomson Reuters Trust Principles.

Search resuls for: "Kabi"

7 mentions found